Our company is a bio venture aimed at global markets as well as Japanese markets in the area of immuno oncology (cancer immunization). We are currently engaged in the field of development of cancer treatments around the world and posses a unique platform technology called a “fusion cell vaccine” that will contribute to the suppression of cancers even to a limited extent in the near future.

We look forward to receiving any inquiries from the investors who are interested in our company, or pharmaceutical companies which are interested in joint development, or biotechnology industries, universities or research organizations that are interested in joint research.

© Copyright 2017 CyTIX Inc. All rights reserved.